Stock FDMT 4D MOLECULAR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Delayed Nasdaq
Other stock markets
 03:45:05 2024-05-02 pm EDT 		5-day change 1st Jan Change
26.32 USD +3.68% Intraday chart for 4D Molecular Therapeutics, Inc. +11.77% +29.81%
Apr. 15 Barclays Starts 4D Molecular Therapeutics With Overweight Rating, $45 Price Target MT
Apr. 15 RBC Raises Price Target on 4D Molecular Therapeutics to $40 From $35, Keeps Outperform Rating, Speculative Risk Qualifier MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bullish

Bullish

Resistance 28.75 35.87 33.60
Spread/Res.-8.52%-26.68%-21.73%
Spread/Supp.+13.12%+52.46%+39.01%
Support 23.25 17.25 18.92

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. FDMT Stock
  4. Charts 4D Molecular Therapeutics, Inc.